vs

Side-by-side financial comparison of CENTRAL GARDEN & PET CO (CENT) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $617.4M, roughly 1.6× CENTRAL GARDEN & PET CO). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs 1.1%, a 4.4% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -6.0%). Everus Construction Group, Inc. produced more free cash flow last quarter ($23.5M vs $-81.0M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs -17.2%).

Central Garden & Pet Co is a leading U.S.-headquartered supplier of pet supplies and garden products. Its portfolio includes pet food, treats, grooming tools, lawn care items, gardening accessories and pest control solutions, serving retail partners like mass merchants, independent pet stores and garden centers across North America with multiple well-known consumer brands in its two core segments.

CENT vs ECG — Head-to-Head

Bigger by revenue
ECG
ECG
1.6× larger
ECG
$1.0B
$617.4M
CENT
Growing faster (revenue YoY)
ECG
ECG
+39.1% gap
ECG
33.2%
-6.0%
CENT
Higher net margin
ECG
ECG
4.4% more per $
ECG
5.5%
1.1%
CENT
More free cash flow
ECG
ECG
$104.5M more FCF
ECG
$23.5M
$-81.0M
CENT
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
-17.2%
CENT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CENT
CENT
ECG
ECG
Revenue
$617.4M
$1.0B
Net Profit
$6.8M
$55.3M
Gross Margin
30.9%
11.6%
Operating Margin
2.7%
6.8%
Net Margin
1.1%
5.5%
Revenue YoY
-6.0%
33.2%
Net Profit YoY
-51.2%
60.4%
EPS (diluted)
$0.11
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CENT
CENT
ECG
ECG
Q4 25
$617.4M
$1.0B
Q3 25
$678.2M
$986.8M
Q2 25
$960.9M
$921.5M
Q1 25
$833.5M
$826.6M
Q4 24
$656.4M
$759.6M
Q3 24
$669.5M
$761.0M
Q2 24
$996.3M
$703.4M
Q1 24
$900.1M
$625.7M
Net Profit
CENT
CENT
ECG
ECG
Q4 25
$6.8M
$55.3M
Q3 25
$-9.8M
$57.0M
Q2 25
$95.0M
$52.8M
Q1 25
$63.6M
$36.7M
Q4 24
$14.0M
$34.5M
Q3 24
$-34.2M
$41.8M
Q2 24
$79.7M
$39.0M
Q1 24
$62.0M
$28.2M
Gross Margin
CENT
CENT
ECG
ECG
Q4 25
30.9%
11.6%
Q3 25
29.0%
12.6%
Q2 25
34.6%
13.0%
Q1 25
32.8%
11.2%
Q4 24
29.8%
11.4%
Q3 24
25.2%
11.8%
Q2 24
31.8%
12.6%
Q1 24
31.0%
11.9%
Operating Margin
CENT
CENT
ECG
ECG
Q4 25
2.7%
6.8%
Q3 25
-0.9%
7.3%
Q2 25
14.1%
7.9%
Q1 25
11.2%
6.2%
Q4 24
4.3%
6.1%
Q3 24
-4.8%
7.1%
Q2 24
11.6%
7.3%
Q1 24
10.4%
6.2%
Net Margin
CENT
CENT
ECG
ECG
Q4 25
1.1%
5.5%
Q3 25
-1.4%
5.8%
Q2 25
9.9%
5.7%
Q1 25
7.6%
4.4%
Q4 24
2.1%
4.5%
Q3 24
-5.1%
5.5%
Q2 24
8.0%
5.5%
Q1 24
6.9%
4.5%
EPS (diluted)
CENT
CENT
ECG
ECG
Q4 25
$0.11
$1.09
Q3 25
$-0.16
$1.11
Q2 25
$1.52
$1.03
Q1 25
$0.98
$0.72
Q4 24
$0.21
$0.68
Q3 24
$-0.51
$0.82
Q2 24
$1.19
$0.76
Q1 24
$0.93
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CENT
CENT
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$721.1M
Total DebtLower is stronger
$1.2B
$281.5M
Stockholders' EquityBook value
$1.6B
$629.8M
Total Assets
$3.6B
$1.7B
Debt / EquityLower = less leverage
0.76×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CENT
CENT
ECG
ECG
Q4 25
$721.1M
Q3 25
$882.5M
Q2 25
$713.0M
Q1 25
$516.7M
Q4 24
$618.0M
Q3 24
$753.5M
$553.0K
Q2 24
$570.4M
Q1 24
$301.3M
Total Debt
CENT
CENT
ECG
ECG
Q4 25
$1.2B
$281.5M
Q3 25
$1.2B
$285.1M
Q2 25
$1.2B
$288.6M
Q1 25
$1.2B
$292.1M
Q4 24
$1.2B
$295.6M
Q3 24
$1.2B
Q2 24
$1.2B
Q1 24
$1.2B
Stockholders' Equity
CENT
CENT
ECG
ECG
Q4 25
$1.6B
$629.8M
Q3 25
$1.6B
$573.0M
Q2 25
$1.6B
$514.4M
Q1 25
$1.5B
$460.2M
Q4 24
$1.5B
$422.6M
Q3 24
$1.6B
$453.3M
Q2 24
$1.6B
$490.0M
Q1 24
$1.5B
$464.3M
Total Assets
CENT
CENT
ECG
ECG
Q4 25
$3.6B
$1.7B
Q3 25
$3.6B
$1.6B
Q2 25
$3.7B
$1.5B
Q1 25
$3.6B
$1.4B
Q4 24
$3.5B
$1.3B
Q3 24
$3.6B
$1.3B
Q2 24
$3.6B
Q1 24
$3.5B
Debt / Equity
CENT
CENT
ECG
ECG
Q4 25
0.76×
0.45×
Q3 25
0.75×
0.50×
Q2 25
0.75×
0.56×
Q1 25
0.77×
0.63×
Q4 24
0.78×
0.70×
Q3 24
0.76×
Q2 24
0.75×
Q1 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CENT
CENT
ECG
ECG
Operating Cash FlowLast quarter
$-70.2M
$48.2M
Free Cash FlowOCF − Capex
$-81.0M
$23.5M
FCF MarginFCF / Revenue
-13.1%
2.3%
Capex IntensityCapex / Revenue
1.8%
2.4%
Cash ConversionOCF / Net Profit
-10.26×
0.87×
TTM Free Cash FlowTrailing 4 quarters
$285.0M
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CENT
CENT
ECG
ECG
Q4 25
$-70.2M
$48.2M
Q3 25
$182.7M
$76.2M
Q2 25
$265.5M
$25.3M
Q1 25
$-46.9M
$7.1M
Q4 24
$-68.8M
Q3 24
$203.1M
$78.9M
Q2 24
$286.1M
Q1 24
$-24.5M
$21.9M
Free Cash Flow
CENT
CENT
ECG
ECG
Q4 25
$-81.0M
$23.5M
Q3 25
$171.9M
$65.7M
Q2 25
$251.7M
$12.3M
Q1 25
$-57.5M
$-11.4M
Q4 24
$-74.9M
Q3 24
$193.0M
$60.9M
Q2 24
$272.5M
Q1 24
$-33.9M
$12.6M
FCF Margin
CENT
CENT
ECG
ECG
Q4 25
-13.1%
2.3%
Q3 25
25.3%
6.7%
Q2 25
26.2%
1.3%
Q1 25
-6.9%
-1.4%
Q4 24
-11.4%
Q3 24
28.8%
8.0%
Q2 24
27.3%
Q1 24
-3.8%
2.0%
Capex Intensity
CENT
CENT
ECG
ECG
Q4 25
1.8%
2.4%
Q3 25
1.6%
1.1%
Q2 25
1.4%
1.4%
Q1 25
1.3%
2.2%
Q4 24
0.9%
Q3 24
1.5%
2.4%
Q2 24
1.4%
Q1 24
1.0%
1.5%
Cash Conversion
CENT
CENT
ECG
ECG
Q4 25
-10.26×
0.87×
Q3 25
1.34×
Q2 25
2.79×
0.48×
Q1 25
-0.74×
0.19×
Q4 24
-4.91×
Q3 24
1.89×
Q2 24
3.59×
Q1 24
-0.40×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CENT
CENT

Garden Products Segment$201.6M33%
Dogand Cat Products$157.0M25%
Other Pet Products$117.8M19%
Manufactured Product Other$102.5M17%
Wild Bird Products$38.5M6%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons